An Open-label, Randomized, 3-way Crossover Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Levofloxacin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 25 Feb 2008 New trial record.